- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Augusta Resource Fights Off Hostile Takeover From Hudbay With Poison Pill
The Financial Post reported today that a British Columbia Securities Commission panel has ruled that a “poison pill” shareholder rights plan for Augusta Resource (TSX:AZC) can stay in place, at least until mid-July, to help stave off a hostile takeover from Hudbay Minerals Inc. (TSX:HBM). Hudbay put forward its $444 million hostile takeover of Augusta in February.
The Financial Post reported today that a British Columbia Securities Commission panel has ruled that a “poison pill” shareholder rights plan for Augusta Resource (TSX:AZC) can stay in place, at least until mid-July, to help stave off a hostile takeover from Hudbay Minerals Inc. (TSX:HBM). Hudbay put forward its $444 million hostile takeover of Augusta in February.
As quoted in the publication:
Vancouver-based Augusta easily won shareholder approval for its rights plan on Friday. The new rules governing poison pills are not decided yet, but the BCSC panel clearly had shareholder support in mind as it granted Augusta a giant extension.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.